Related Experiment Video

Updated: Aug 9, 2025

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.6K

Immunotherapeutic Approaches in Ovarian Cancer

Hyunho Yoon1,2, Ayoung Kim1, Hoon Jang3

  • 1Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.

Current Issues in Molecular Biology
|February 24, 2023
PubMed

Insights

Next-generation sequencing (NGS) advances ovarian cancer (OC) diagnosis by analyzing the transcriptome. This review covers NGS applications and immunotherapies like CAR-T cells for effective OC treatment.

Area of Science:

  • Gynecological Oncology
  • Genomics
  • Immunotherapy

Background:

  • Ovarian cancer (OC) diagnosis and treatment are rapidly evolving fields.
  • Next-generation sequencing (NGS) offers novel molecular insights into cancer.
  • NGS applications are expanding in OC research for early detection and pathway identification.

Purpose of the Study:

  • To review NGS-based diagnostic applications for ovarian cancer.
  • To introduce current immunotherapeutic strategies for OC treatment.
  • To highlight the synergy between NGS and immunotherapy in managing OC.

Main Methods:

  • Literature review of NGS applications in OC research.
  • Analysis of current immunotherapeutic approaches including vaccines, checkpoint inhibitors, and CAR-T cell therapy.
  • Integration of diagnostic and therapeutic advancements in OC management.

Main Results:

  • NGS provides comprehensive transcriptome views, identifying fusion genes, mutations, and expression profiles in OC.
  • Immunotherapy has shown clinical efficacy in ovarian cancer, similar to other cancer types.
  • NGS facilitates the identification of therapeutic targets for molecular targeted therapy and immunotherapy in OC.

Conclusions:

  • NGS-based diagnostics are crucial for understanding OC at a molecular level.
  • Immunotherapy represents a promising treatment modality for ovarian cancer.
  • Combining NGS with advanced immunotherapies offers a powerful strategy for improved OC diagnosis and treatment.
Keywords:
immunotherapynext-generation sequencingovarian cancer

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.3K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
612
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
469
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K